Diabetes drugs and body changes: a research imaging study
Part of Hormones & metabolism clinical trials.
This study looks at how newer diabetes medications (semaglutide or tirzepatide) affect your body shape, muscle, and fat. If you have type 2 diabetes and just started one of these drugs, researchers want to learn more about changes in your body using imaging scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have type 2 diabetes.
- You recently started taking semaglutide or tirzepatide (like Ozempic, Wegovy, Mounjaro, or Zepbound) under a doctor's care.
- You can speak and read English.
- You are not pregnant or breastfeeding.
- You have not lost more than 11 pounds (5 kg) in the 90 days before starting your diabetes medication.
- You have not had bariatric surgery in the past or plan to have it in the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look at how the diabetes medication semaglutide affects body composition in people with type 2 diabetes and obesity. It may help doctors understand how this treatment works in the body.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study looks at how semaglutide (Ozempic or Wegovy) changes heart muscle and body muscle. It may help people with type 2 diabetes or those taking the drug for weight loss understand if their heart is affected.
This study looks at how semaglutide (a medication for type 2 diabetes or weight management) affects your heart, kidneys, and overall metabolic health over time. It uses medical records from LMC endocrinology clinics to track real-world outcomes.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This trial looks at how two weight-loss medications, semaglutide and tirzepatide, affect your body's fat and muscle. It may help you understand if these medications improve your overall health beyond just weight loss.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.